News Daily News Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US Yael L. Maxwell December 07, 2017
News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Daily News Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events Todd Neale September 25, 2017
News Daily News Secondary Prevention Lagging Behind in Women With Established Coronary Disease Todd Neale September 22, 2017
News Features COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict Todd Neale September 15, 2017
News Conference News ESC 2017 P2Y12 Inhibitor Pretreatment Questioned in STEMI Todd Neale August 29, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
News Daily News Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment Todd Neale July 20, 2017
News Daily News More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis Michael O'Riordan July 03, 2017
News Daily News Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice Caitlin E. Cox March 10, 2017
News Daily News Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS Todd Neale February 08, 2017